Abstract: Embodiments relate to a one-component type paint composition with superior scratch resistance and secures excellent scratch restoring performance by including a resin, a curing agent, a curing catalyst and an organic solvent, whereby the resin includes: 30 to 70 wt % of a carbamate group-containing acrylic polyol resin; and 5 to 25 wt % of a hyperbranched structure carbamate group-containing polyester polyol resin, based on 100 wt % of the paint composition.

Abstract: Embodiments relate to a one-component type paint composition with superior scratch resistance and secures excellent scratch restoring performance by including a resin, a curing agent, a curing catalyst and an organic solvent, whereby the resin includes: 30 to 70 wt % of a carbamate group-containing acrylic polyol resin; and 5 to 25 wt % of a hyperbranched structure carbamate group-containing polyester polyol resin, based on 100 wt % of the paint composition.

Abstract: The present invention relates to an interleukin-2 receptor gamma (IL2RG) gene-targeting vector, a method for producing an immune cell-deficient transgenic cloned miniature pig having the vector introduced therein, and the use thereof.

Abstract: There are provided to a Rag-2 (Recombination activating gene 2) gene targeting vector, a method for producing SCID-like miniature pigs introduced with the vector, and a use thereof.

Abstract: There are provided to a Rag-2 (Recombination activating gene 2) gene targeting vector, a method for producing SCID-like miniature pigs introduced with the vector, and a use thereof.

Abstract: The present invention relates to an interleukin-2 receptor gamma (IL2RG) gene-targeting vector, a method for producing an immune cell-deficient transgenic cloned miniature pig having the vector introduced therein, and the use thereof

Abstract: There is provided a CMP-acetylneuraminic acid hydroxylase targeting vector, a transgenic animal for xenotransplantation introduced with the vector, and a method of manufacturing the same. The targeting vector and the cell line for transformation prepared by the present invention can be used for the efficient production of cloned pigs for xenotransplantation by the complex regulation of the expression of the genes involved in the immunological rejection responses.

Abstract: Disclosed are a hand-tearable adhesive tape which is made of a sheet woven with warps and wefts, in which the warps have a smaller titer than the wefts, and is coated with a flame retardant to provide flame retardancy and is with an adhesive agent, and a method for manufacturing the same. Advantageously, the hand-tearable adhesive tape can exhibit superior adhesive force, while providing flame retardancy and can be torn by hand.

Abstract: The present invention provides a porcine beta-casein gene, a porcine beta-casein gene promoter, an expression vector comprising the same promoter, and a method for the production of a target protein using the same expression vector. The promoter of the present invention facilitates mammary gland-specific expression of the target protein and therefore can be useful for high-concentration production of beneficial proteins in milk.

Abstract: Disclosed are a hand-tearable adhesive tape which is made of a sheet woven with warps and wefts, in which the warps have a smaller titer than the wefts, and is coated with a flame retardant to provide flame retardancy and is with an adhesive agent, and a method for manufacturing the same. Advantageously, the hand-tearable adhesive tape can exhibit superior adhesive force, while providing flame retardancy and can be torn by hand.

Abstract: The present invention provides a porcine beta-casein gene, a porcine beta-casein gene promoter, an expression vector comprising the same promoter, and a method for the production of a target protein using the same expression vector. The promoter of the present invention facilitates mammary gland-specific expression of the target protein and therefore can be useful for high-concentration production of beneficial proteins in milk.

Abstract: The present invention provides a mammary gland-specific human erythropoietin expression (hEPO) vector, transgenic animal and method for producing human erythropoietin using the same. The inventive hEPO-expressing transgenic animals express a mammary gland-specific EPO at an extremely higher concentration than the convention method. The hEPO produced from inventive transgenic animals shows better stability and superior physiological activity than those of the same kind of commerally available protein. Therefore, the inventive hEPO-expressing transgenic animals can be effectively used for production of EPO showing a superior physiological activity than the existing EPO.

Abstract: The present invention relates to a porcine uroplakin II gene promoter, an expression vector containing the promoter, and a method for producing useful proteins using the vector. The promoter of the present invention promotes the bladder-specific expression of a target protein at high efficiency. An animal, which was transformed using the inventive promoter so as to express the target protein, secretes the target protein in its urine at high concentration, and the protein thus produced shows a superior physiological activity to that of the same kind of the existing protein. As a result, the inventive promoter, the expression vector and transgenic animal using the promoter, can be advantageously used in the production field of useful proteins that are medicinally valuable.

Abstract: The present invention relates to a porcine uroplakin II gene promoter, an expression vector containing the promoter, and a method for producing useful proteins using the vector. The promoter of the present invention promotes the bladder-specific expression of a target protein at high efficiency. An animal, which was transformed using the inventive promoter so as to express the target protein, secretes the target protein in its urine at high concentration, and the protein thus produced shows a superior physiological activity to that of the same kind of the existing protein. As a result, the inventive promoter, the expression vector and transgenic animal using the promoter, can be advantageously used in the production field of useful proteins that are medicinally valuable.